320 related articles for article (PubMed ID: 18389145)
1. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
2. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
3. Protoporphyrin IX-gold nanoparticle conjugates as an efficient photosensitizer in cervical cancer therapy.
Eshghi H; Sazgarnia A; Rahimizadeh M; Attaran N; Bakavoli M; Soudmand S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):304-12. PubMed ID: 23993857
[TBL] [Abstract][Full Text] [Related]
4. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
5. Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity.
Frochot C; Di Stasio B; Vanderesse R; Belgy MJ; Dodeller M; Guillemin F; Viriot ML; Barberi-Heyob M
Bioorg Chem; 2007 Jun; 35(3):205-20. PubMed ID: 17223161
[TBL] [Abstract][Full Text] [Related]
6. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
7. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of protoporphyrin IX performance in aqueous solutions for photodynamic therapy.
Homayoni H; Jiang K; Zou X; Hossu M; Rashidi LH; Chen W
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):258-66. PubMed ID: 25636780
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy using intravenous delta-aminolaevulinic acid-induced protoporphyrin IX sensitisation in experimental hepatic tumours in rats.
Svanberg K; Liu DL; Wang I; Andersson-Engels S; Stenram U; Svanberg S
Br J Cancer; 1996 Nov; 74(10):1526-33. PubMed ID: 8932330
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers.
Lilge L; Wilson BC
J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099
[TBL] [Abstract][Full Text] [Related]
12. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
13. Exploiting the Cellular Redox-Control System for Activatable Photodynamic Therapy.
Gharibi N; Kailass K; Beharry AA
Chembiochem; 2019 Feb; 20(3):345-349. PubMed ID: 30423216
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
15. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Tyrrell J; Campbell S; Curnow A
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):86-97. PubMed ID: 20510303
[TBL] [Abstract][Full Text] [Related]
16. Diamino acid derivatives of PpIX as potential photosensitizers for photodynamic therapy of squamous cell carcinoma and prostate cancer: in vitro studies.
Kwitniewski M; Juzeniene A; Ma LW; Glosnicka R; Graczyk A; Moan J
J Photochem Photobiol B; 2009 Mar; 94(3):214-22. PubMed ID: 19136276
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
Kleemann D; MacRobert AJ; Mentzel T; Speight PM; Bown SG
Br J Cancer; 1996 Jul; 74(1):49-58. PubMed ID: 8679457
[TBL] [Abstract][Full Text] [Related]
18. Extending the tissue penetration capability of conventional photosensitisers: a carbon quantum dot-protoporphyrin IX conjugate for use in two-photon excited photodynamic therapy.
Fowley C; Nomikou N; McHale AP; McCaughan B; Callan JF
Chem Commun (Camb); 2013 Oct; 49(79):8934-6. PubMed ID: 23970216
[TBL] [Abstract][Full Text] [Related]
19. Facile one-pot synthesis of cyclic peptide-conjugated photosensitisers for targeted photodynamic therapy.
Chu JCH; Yang C; Fong WP; Wong CTT; Ng DKP
Chem Commun (Camb); 2020 Oct; 56(80):11941-11944. PubMed ID: 32931540
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
